首页 | 本学科首页   官方微博 | 高级检索  
检索        

多西紫杉醇、5-氟尿嘧啶联合顺铂对晚期胃癌的疗效及安全性评价
引用本文:张爱虹,李长福,冯小东,侯宇澄.多西紫杉醇、5-氟尿嘧啶联合顺铂对晚期胃癌的疗效及安全性评价[J].中国药房,2011(26):2474-2476.
作者姓名:张爱虹  李长福  冯小东  侯宇澄
作者单位:哈尔滨医科大学附属肿瘤医院药剂科;哈尔滨医科大学附属肿瘤医院外科;
摘    要:目的:评价多西紫杉醇、5-氟尿嘧啶联合顺铂对晚期胃癌的疗效及安全性。方法:58例晚期胃癌患者随机分为对照组与治疗组,每组29例。对照组给予5-氟尿嘧啶+顺铂;治疗组给予多西紫杉醇+5-氟尿嘧啶+顺铂。以21d为1个周期,治疗2个周期后评价疗效及安全性。结果:对照组总有效率为37.93%,治疗组总有效率为55.17%,2组比较差异有统计学意义(P<0.05);2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:多西紫杉醇、5-氟尿嘧啶联合顺铂治疗晚期胃癌效果显著,不增加不良反应,安全性高,值得临床推广应用。

关 键 词:多西紫杉醇  5-氟尿嘧啶  顺铂  晚期胃癌

Efficacy and Safety Evaluation of Docetaxel,5-fluorouracil and Cisplatin in the Treatment of Advanced Gastric Cancer
ZHANG Ai-hong,FENG Xiao-dong,HOU Yu-chengLI Chang-fu.Efficacy and Safety Evaluation of Docetaxel,5-fluorouracil and Cisplatin in the Treatment of Advanced Gastric Cancer[J].China Pharmacy,2011(26):2474-2476.
Authors:ZHANG Ai-hong  FENG Xiao-dong  HOU Yu-chengLI Chang-fu
Institution:ZHANG Ai-hong,FENG Xiao-dong,HOU Yu-cheng(Dept.of Pharmacy,The Affiliated Tumor Hospital of Harbin Medical University,Harbin 150040,China)LI Chang-fu(Dept. of Surgery,China)
Abstract:OBJECTIVE:To evaluate the clinical efficacy and safety of docetaxel and 5-fluorouracil combined with cisplatin in the treatment of advanced gastric cancer. METHODS: 58 cases of advanced gastric cancer were randomly divided into treatment group and control group, 29 cases in each group. Control group were given 5-fluorouracil and cisplatin, and treatment group were given 5-fluorouracil, cisplatin and docetaxel. A cycle lasted for 21 days. After two cycles, the clinical efficacy and safety were evaluated. RES...
Keywords:Docetaxel  5-fluorouracil  Cisplatin  Advanced gastric cancer  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号